CSIMarket
 


Can fite Biopharma Ltd   (CANF)
Other Ticker:  
 

Can Fite Biopharma Ltd 's Total Debt to Equity

CANF's quarterly Total Debt to Equity and Total Debt, Equity growth


In the forth quarter 2022 Can Fite Biopharma Ltd did not have Total Debt.

Within Major Pharmaceutical Preparations industry Can fite Biopharma Ltd achieved the lowest Total Debt to Equity in the forth quarter 2022. While total ranking remained the same in the forth quarter 2022 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of CANF´s Total Debt?
How valuable is the CANF´s Equity?


CANF Total Debt to Equity (Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Change -68.91 % -68.91 % -68.91 % -68.91 % 136.78 %
Y / Y Total Debt Change - - - - -
Total Debt to Equity MRQ - - - - -
CANF's Total Ranking # # # # #
Seq. Equity Change 0 % 0 % 0 % -68.91 % 0 %
Seq. Total Debt Change - - - - -



Total Debt to Equity forth quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Can Fite Biopharma Ltd 's Equity $ 4 Millions Visit CANF's Balance sheet
Can Fite Biopharma Ltd 's Total Debt $ 0 Millions Visit CANF's Balance sheet
Source of CANF's Sales Visit CANF's Sales by Geography


Cumulative Can Fite Biopharma Ltd 's Total Debt to Equity

CANF's Total Debt to Equity for the trailling 12 Months

CANF Total Debt to Equity

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity TTM Growth -68.91 % -68.91 % -68.91 % -68.91 % 136.78 %
Y / Y Total Debt TTM Growth - - - - -
Total Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth 0 % 0 % 0 % -68.91 % 0 %
Seq. Total Debt TTM Growth - - - - -


On the trailing twelve months basis During the twelve months ending IV Quarter 2022 Can Fite Biopharma Ltd did not have Total Debt .
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry CANF recorded the lowest Total Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Debt to Equity Ratio?
What is the structure of CANF´s Total Debt?
How valuable is the CANF´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Total Debt to EquityDec 31 2022 MRQ Total DebtDec 31 2022 MRQ Equity

Date modified: 2023-04-01T21:33:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com